Bliss, Caleb
Apellis Pharmaceuticals (United States)
3 papers on CoChat
Most cited papers
- Verified
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 520
- Verified
Screening and Brief Intervention to Reduce Marijuana Use Among Youth and Young Adults in a Pediatric Emergency Department
Bernstein, E., Edwards, E., Dorfman, D., Heeren, T., Bliss, C., & Bernstein, J. (2009) · Academic Emergency Medicine
Substance Abuse Treatment and OutcomesCannabis and Cannabinoid Research
Cited by 207
- Verified
A brief motivational interview in a pediatric emergency department, plus 10-day telephone follow-up, increases attempts to quit drinking among youth and young adults who screen positive for problematic drinking
Bernstein, J., Heeren, T., Edward, E., Dorfman, D., Bliss, C., Winter, M., & Bernstein, E. (2010) · Academic Emergency Medicine
Substance Abuse Treatment and OutcomesSmoking Behavior and Cessation
Cited by 120
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free